ELOXX PHARMACEUTICALS INC (ELOX)
US29014R2022 - Common Stock
| TTM (2023-6-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -24.40M | -36.06M | -66.73M | -34.58M | -50.87M | |||
| Depreciation Amortization | 60.00K | 77.00K | 114.00K | 70.00K | 90.00K | |||
| Income Taxes - Deferred | N/A | N/A | N/A | N/A | N/A | |||
| Change In Working Capital | -1.18M | -118.00K | -1.03M | -3.40M | -640.00K | |||
| Interest Paid | 1.38M | 1.36M | 728.00K | 830.00K | 990.00K | |||
| Taxes Paid | N/A | N/A | 0.00 | 10.00K | 40.00K | |||
| Other non cash items | 4.03M | 4.26M | 32.65M | 9.75M | 12.04M | |||
| OPERATING CASH FLOW | -21.49M | -31.84M | -35.00M | -28.17M | -39.39M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -48.00K | -66.00K | -89.00K | N/A | -40.00K | |||
| Other Investing Activity | 25.00K | 0.00 | 2.15M | 33.79M | -33.48M | |||
| INVESTING CASH FLOW | -23.00K | -66.00K | 2.06M | 33.79M | -33.52M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -7.50M | 0.00 | 491.00K | -3.79M | 15.00M | |||
| Stock Issued/Repurchased | N/A | 0.00 | 47.74M | 70.00K | 33.05M | |||
| Other Financing Activity | 1.81M | 8.81M | 2.56M | 280.00K | -1.25M | |||
| FINANCING CASH FLOW | -4.26M | 8.81M | 50.79M | -3.44M | 46.80M | |||
| CHANGE IN CASH | -25.77M | -23.10M | 17.84M | 2.18M | -26.11M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -21.49M | -31.84M | -35.00M | -28.17M | -39.39M | |||
| Capital Expenditure | -48.00K | -66.00K | -89.00K | N/A | -40.00K | |||
| FREE CASH FLOW | -21.53M | -31.91M | -35.09M | -28.17M | -39.43M | |||
All data in USD